The National Basketball Association’s (NBA) Atlanta Hawks are close to offloading a minority stake to US private equity firm Dyal HomeCourt Partners would value the team at around US$2 billion.
It is unclear how big HomeCourt’s share would be.
The Hawks were recently valued by sports business publication Sportico at US$1.83 billion, marking a 19 percent increase over the past 12 months.
Sportico attributed the growth to the team’s Eastern Conference finals stint during the 2020/21 season and the planned US$5 billion real estate development next to the franchise’s State Farm Arena.
In 2015, the team was purchased by a group led by Ressler for a reported US$730 million.
Dyal HomeCourt, a division of Blue Owl Capital, is among several firms that have invested in NBA teams since the league updated its policy to allow private equity to own up to 20 percent of a single franchise and invest in as many as five teams.
The company already holds minority stakes in other NBA teams, including the Sacramento Kings and the Phoenix Suns.


LA28 Confirms Olympic Athletes Exempt from Trump’s Travel Ban
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump to Host UFC Event at White House on His 80th Birthday
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
US Reviewing Visa Denial for Venezuelan Little League Team Barred from World Series
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



